Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,231,524 papers from all fields of science
Search
Sign In
Create Free Account
proAVP hormone
Known as:
proAVP
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Vasopressins
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Higher plasma levels of CT-proAVP are linked to less anxiety in men but not women with cardiovascular risk factors: Results from the observational Diast-CHF study
Monika Sadlonova
,
T. Meyer
,
L. Binder
,
R. Wachter
,
F. Edelmann
,
C. Herrmann-Lingen
Psychoneuroendocrinology
2019
Corpus ID: 56476057
2019
2019
Cardiac biomarkers and bone fractures
A. Ribeiro
,
C. Otto
Heart
2019
Corpus ID: 73488299
Fragility-related fractures and cardiovascular disease are common conditions in old age, both contributing to impaired quality of…
Expand
Review
2017
Review
2017
Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease.
E. Gołembiewska
,
A. Machowska
,
P. Stenvinkel
,
B. Lindholm
Current protein and peptide science
2017
Corpus ID: 25300746
Arginine vasopressin (AVP), also known as antidiuretic hormone (ADH), is released in response to osmotic and non-osmotic stimuli…
Expand
2015
2015
Ct-proAVP is Not a Good Predictor of Vasopressor Need in Septic Shock
S. Laribi
,
D. Lienart
,
D. Castanares-Zapatero
,
C. Collienne
,
X. Wittebole
,
P. Laterre
Shock
2015
Corpus ID: 5068641
Introduction: Septic shock features a high hospital mortality. Improving our ability to risk stratify these patients at admission…
Expand
Review
2015
Review
2015
GDF-15, MRproADM, CTproET1 und CTproAVP bei Patienten mit asymptomatischer diastolischer Dysfunktion
Kathleen Nolte
,
F. Gabriel
,
+5 authors
F. Edelmann
DMW Deutsche Medizinische Wochenschrift
2015
Corpus ID: 8443065
Zusammenfassung Hintergrund und Fragestellung | Die Rolle von Biomarkern bei asymptomatischer diastolischer Dysfunktion (DD) ist…
Expand
2014
2014
Vasopressin and CTproAVP in pathogenetic conditions Diabetes insipidus
D. Bolignano
,
E. Fiaccadori
,
+7 authors
A. Peracino
2014
Corpus ID: 42773156
Arginine vasopressin (AVP) plays a key role in many physiologic and pathologic processes. The most important stimulus for AVP…
Expand
2011
2011
Stellenwert von CT-proAVP (Copeptin) in der Abklärung des Polyurie-Polydipsie Syndroms
W. Fenske
,
M. Christ-Crain
2011
Corpus ID: 70831245
Die Differenzialdiagnose einer primaren Polydipsie und eines Diabetes insipidus ist oft sehr anspruchsvoll. In der Routine wird…
Expand
2010
2010
Detection of Provasopressin in Invasive and Non-invasive (DCIS) Human Breast Cancer Using a Monoclonal Antibody Directed Against the C-terminus (MAG1)
B. Keegan
,
V. Memoli
,
W. Wells
,
W. North
Breast cancer : basic and clinical research
2010
Corpus ID: 17664382
The provasopressin protein (proAVP) is expressed by invasive breast cancer and non-invasive breast cancer, or ductal carcinoma in…
Expand
2007
2007
Midregional ProA-Type Natriuretic Peptide and Carboxy-Terminal Provasopressin May Predict Prognosis in Community-Acquired Pneumonia
M. Masiá
,
J. Papassotiriou
,
N. Morgenthaler
,
I. Hernández
,
C. Shum
,
F. Gutiérrez
2007
Corpus ID: 46313201
Background: Markers to better assess severity of disease in patients with community-acquired pneumonia (CAP) would help improve…
Expand
2002
2002
Glucocorticoid treatment is associated with decreased expression of processed AVP but not of proAVP, neurophysin or oxytocin in the human hypothalamus: are PC1 and PC2 involved?
Z. Erkut
,
B. Gabreëls
,
J. Eikelenboom
,
F. V. van Leeuwen
,
D. Swaab
Neuro - endocrinology letters
2002
Corpus ID: 12033256
OBJECTIVES We reported earlier that vasopressin (AVP) peptide expression is significantly decreased in the postmortem…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE